ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow turns positive
Q1 FY2026 financing cash flow was $43.17M, compared with -$225.1K a year earlier. Trailing-twelve-month financing cash flow was $394.19M. Over 3 fiscal years it compounded at +275.2% a year.
Context
- Financing cash flow amounted to 1470.9% of revenue in FY2025, down 520.7 pp from a year earlier.
- Financing cash flow increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly financing cash flow holds near $43.17M or moves back toward the trailing-twelve-month quarterly average of $98.55M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 350.8M USD
- Year-over-year change
- +325.0%
- 4-year CAGR
- +171.0%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 350.8M | +325.0% |
| FY2024 | 2024-12-31 | 82.53M | +516.6% |
| FY2023 | 2023-12-31 | 13.39M | +101.6% |
| FY2022 | 2022-12-31 | 6.64M | +2.2% |
| FY2021 | 2021-12-31 | 6.5M | — |
Financing Cash Flow vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +544.0% is the 3rd highest of 11, against a peer median of +217.9%.
- Financing cash flow amounts to 1463.9% of revenue for ASPI, versus a peer median of 9.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$2.91B BRL | +437.8% | +140.6% | 4.4% | |
| LTM Mar 2026 | $612.65M USD | +618.0% | +31.9% | 458.8% | |
| LTM Mar 2026 | $394.19M USD | +544.0% | +275.2% | 1463.9% | |
| LTM Mar 2026 | $348.8M USD | -5.0% | -6.9% | 28.2% | |
| LTM Mar 2026 | $281M USD | +473.5% | — | 9.6% | |
| LTM Mar 2026 | $239.04M USD | +274.6% | +113.0% | 12.3% | |
| LTM Mar 2026 | $118.8M USD | +50.4% | +96.4% | 9.2% | |
| LTM Mar 2026 | $103.68M USD | +1315.3% | — | 265.6% | |
| LTM Mar 2026 | $44.6M USD | +104.8% | — | 1.9% | |
| LTM Apr 2026 | $23.49M USD | +101.5% | — | 4.8% | |
| LTM Mar 2026 | $13.49M USD | +161.1% | — | 1.0% | |
| Peer median (excluding ASPI) | — | +217.9% | +96.4% | 9.4% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.61M) | (4.95M) | (16.29M) | (32.42M) | (159.84M) |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471.42B | 1.91M |
| Deferred Income Tax | 0 | (72.57K) | 16.66K | (143.28K) | (45K) |
| Stock-Based Compensation | 0 | 2M | 8.74M | 8.56M | 16.02M |
| Change in Working Capital | (238.21K) | 33.89K | 1.16M | (2.62M) | (3.63M) |
| Accounts Receivables | 0 | 0 | 237.95K | (505.95K) | (454K) |
| Inventory | 0 | 0 | 0 | (67.64K) | (315K) |
| Accounts Payables | 59.68K | 570.6K | (224.6K) | (877.47K) | 782K |
| Other Working Capital | (297.89K) | (536.71K) | 1.15M | (1.17M) | (3.64M) |
| Other Non-Cash Items | 2.23M | (27.96K) | 924.12K | (471.41B) | 107.8M |
| Operating Cash Flow | (577.69K) | (2.94M) | (5.41M) | (16.7M) | (37.78M) |
| Capital Expenditures | (2.99M) | (4.47M) | (2.33M) | (11.37M) | (9.65M) |
| Acquisitions (Net) | 0 | 0 | (121.85K) | 0 | 25.37M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (75.74M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (29.97M) |
| Investing Cash Flow | (2.99M) | (4.47M) | (2.45M) | (11.37M) | (90M) |
| Debt Repayment | 46.9K | (13.05K) | (180.53K) | 25.72M | 44.11M |
| Common Stock Issued | 6.45M | 8.12M | 14.13M | 53.09M | 307.09M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (2.78T) | 0 |
| Other Financing Activities | 0 | (1.47M) | (563.47K) | 2.78T | (402K) |
| Financing Cash Flow | 6.5M | 6.64M | 13.39M | 82.53M | 350.8M |
| Effect of Forex Changes | 18.72K | 207.42K | (867) | (484.01K) | 646.95K |
| Net Change in Cash | 2.93M | (564.58K) | 5.52M | 53.98M | 223.67M |
| Free Cash Flow | (3.57M) | (7.41M) | (7.74M) | (28.07M) | (47.43M) |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.